CLSI I/LA30-A

Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE

Clinical and Laboratory Standards Institute, 02/01/2008

Publisher: CLSI

File Format: PDF

$108.00$216.21

Description

Published:01/02/2008

Pages:44

Clinical and Laboratory Standards Institute document I/LA30-A—Immunoassay Interference by Endogenous Antibodies; Approved Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.

More CLSI standard pdf

CLSI EP17A

Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline, EP17-A

$112.00 $225.01

CLSI I/LA26-A

Performance of Single Cell Immune Response Assays; Approved Guideline, ILA26A

$137.00 $275.76

CLSI GP43-A4

Procedures for the Collection of Arterial Blood Specimens; Approved Standard, GP43A4E

$125.00 $251.43

CLSI EP05-A2

Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline, EP05A2E

$116.00 $233.97